cemiplimab
sanofi,regeneron
['lcsm,(-blcsm)', 'cemiplimab', 'myeloid', 'nsclc', 'sclc', 'thanks']
we recently interviewed dr joseph murray of on the use of peripheral myeloid cells as prognostic markers in patients with nsclc treated with cemiplimab. thanks for stopping by and sharing your insights! #asco23 #asco2023 #lcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.